2Matthew T, Boehme R. Antiviral activity and mechanism of action of ganciclovir. Reviews of infectious diseases, 1988, 10(Suppl. 1 ) :490.
3Pouliquen P, Elena PP, Malecaze F et al . Assessment of the safety and local pharmacokinetics of 0.15% gel of ganciclovir (Virgan) in healthy volunteers. Invest Ophthalmol Vis Sci, 1996,37(3):313.
4Colin J, Hoh HB. Ganciclovir ophthalmic gel (Virgan 0.15%) in the treatment of herpes simplex keratitis. Cornea, 1997,16(4) :393.
5Hoh HB, Hurley C, Claoue C et al . Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study. Br J Ophthalmol, 1996,80 (3):140.
